Inhibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK/PD relationships

Pharmacological Research

Volumn 63, Issue 5, 2011, Pages 432-438

  Prémaud, Aurélie ^a,b   Rousseau, Annick ^a,b   Johnson, Gyasi ^a,b   Canivet, Cindy ^c   Gandia, Peggy ^d   Muscari, Fabrice ^c,e   Peron, Jean Marie ^d,e   Rostaing, Lionel ^c,d,e   Marquet, Pierre ^a,b,f   Kamar, Nassim ^c,d,e  

^a INSERM   (France)

^b UNIVERSITY OF LIMOGES   (France)

^c CHU RANGUEIL   (France)

^d CHU PURPAN   (France)

^e UNIVERSITÉ PAUL SABATIER   (France)

^f LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Lymphocyte functions; Mycophenolate mofetil; Mycophenolic acid concentrations

Indexed keywords

CD71 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LIVER TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MALE; MORNING DOSAGE; PHARMACODYNAMICS; PRIORITY JOURNAL; SINGLE DRUG DOSE; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; T-LYMPHOCYTES;

EID: 79955476791     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2011.01.005     Document Type: Article

References (30)

1. P.F. Halloran Immunosuppressive drugs for kidney transplantation N Engl J Med 351 2004 2715 2729 (Pubitemid 39665325)
2. A.C. Allison, and E.M. Eugui Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection Transplantation 80 2005 S181 S190
3. C.E. Staatz, and S.E. Tett Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients Clin Pharmacokinet 46 2007 13 58 (Pubitemid 46091591)
4. P. Glander, P. Hambach, K.P. Braun, L. Fritsche, M. Giessing, and I. Mai Pre-transplant inosine monophosphate dehydrogenase activity is associated with clinical outcome after renal transplantation Am J Transplant 4 2004 2045 2051 (Pubitemid 39611633)
5. T. Böhler, J. Nolting, N. Kamar, P. Gurragchaa, K. Reisener, and P. Glander Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans Ther Drug Monit 29 2007 77 86 (Pubitemid 46279880)
6. T. Böhler, C. Canivet, S. Galvani, N. Therville, R. Salvayre, and A. Negre-Salvayre Pharmacodynamic monitoring of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable kidney-allograft recipients Int Immunopharmacol 8 2008 769 773
7. E.M. Eugui, S.J. Almquist, C.D. Muller, and A.C. Allison Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion Scand J Immunol 33 1991 161 173
8. A.W. Thomson, J. Woo, G.Z. Yao, S. Todo, T.E. Starzl, and A. Zeevi Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures Transpl Immunol 1 1993 146 150
9. M.J. Barten, M. Shipkova, P. Bartsch, S. Dhein, F. Streit, and A. Tarnok Mycophenolic acid interaction with cyclosporine and tacrolimus in vitro and in vivo: evaluation of additive effects on rat blood lymphocyte function Ther Drug Monit 27 2005 123 131 (Pubitemid 40463637)
10. N. Kamar, P. Glander, J. Nolting, T. Böhler, P. Hambach, and L. Liefeldt Pharmacodynamic evaluation of the first dose of mycophenolate mofetil before kidney transplantation Clin J Am Soc Nephrol 4 2009 936 942
11. N. Kamar, P. Glander, J. Nolting, T. Böhler, P. Hambach, and L. Liefeldt Effect of mycophenolate mofetil monotherapy on T-cell functions and inosine monosphosphate dehydrogenase activity in patients undergoing a kidney transplantation Transplant Proc 38 2006 2292 2294 (Pubitemid 46068534)
12. L. Quéméneur, M. Flacher, L.M. Gerland, M. Ffrench, J.P. Revillard, and N. Bonnefoy-Berard Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis J Immunol 169 2002 2747 2755 (Pubitemid 34921024)
13. M.J. Barten, T. van Gelder, J.F. Gummert, R. Shorthouse, and R.E. Morris Novel assays of multiple lymphocyte functions in whole blood measure: new mechanisms of action of mycophenolate mofetil in vivo Transpl Immunol 10 2002 1 14 (Pubitemid 34863319)
14. G.R. Hayes, A. Williams, C.E. Costello, C.A. Enns, and J.J. Lucas The critical glycosylation site of human transferrin receptor contains a high-mannose oligosaccharide Glycobiology 5 1995 227 232
15. A.C. Allison, and E.M. Eugui Purine metabolism and immunosuppressive effects of mycophenolate mofetil [MMF] Clin Transplant 10 1996 77 84 (Pubitemid 26076435)
16. A.F. Laurent, S. Dumont, P. Poindron, and C.D. Muller Mycophenolic acid suppresses protein N-linked glycosylation in human monocytes and their adhesion to endothelial cells and to some substrates Exp Hematol 24 1996 59 67 (Pubitemid 26041775)
17. T. Mustelin GTP dependence of the transduction of mitogenic signals through the T3 complex in T lymphocytes indicates theinvolvement of a G-protein FEBS Lett 213 1987 199 203 (Pubitemid 17036153)
18. A.W. Thomson, J. Woo, G.Z. Yao, S. Todo, T.E. Starzl, and A. Zeevi Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T-cell activation molecule expression in human mixed lymphocyte cultures Transpl Immunol 1 1993 146 150
19. S.E. Nagy, J.P. Andersson, and U.G. Andersson Effect of mycophenolate mofetil ŽRS-61443 on cytokine production: inhibition of superantigen-induced cytokines Immunopharmacology 26 1993 11 20 (Pubitemid 23216870)
20. A.C. Allison, and E.M. Eugui Mycophenolate mofetil and its mechanisms of action Immunopharmacology 47 2000 85 118 (Pubitemid 30394534)
21. A. Prémaud, L.T. Weber, B. Tönshoff, V.W. Armstrong, M. Oellerich, and S. Urien Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches Pharmacol Res 2010 doi:10.1016/j.phrs.2010.10.017
22. F.T. Musuamba, A. Rousseau, J.L. Bosmans, J.J. Senessael, J. Cumps, and P. Marquet Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus Clin Pharmacokinet 48 11 2009 745 758
23. A. Prémaud, J. Debord, A. Rousseau, Y. Le Meur, O. Toupance, and Y. Lebranchu A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetil Clin Pharmacokinet 44 2005 837 847 (Pubitemid 41126931)
24. M. Naesens, D.R.J. Kuypers, K. Verbeke, and Y. Vanrenterghem Multidrug Resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients Transplantation 2 8 2006 1074 1084 (Pubitemid 44632124)
25. Y. Le Meur, M. Büchler, A. Thierry, S. Caillard, F. Villemain, and S. Lavaud Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation Am J Transplant 7 2007 2496 2503 (Pubitemid 47566324)
26. A. Prémaud, A. Rousseau, Y. Le Meur, N. Venisse, C. Loichot, and A. Turcant Feasibility of, and critical paths for mycophenolate mofetil Bayesian dose adjustment: pharmacological re-appraisal of a concentration-controlled versus fixed-dose trial in renal transplant recipients Pharmacol Res 61 2 2010 167 174
27. T. van Gelder, H.T. Silva, J.W. de Fijter, K. Budde, D. Kuypers, and G. Tyden Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial Transplantation 86 8 2008 1043 1051
28. L.M. Shaw, M. Korecka, D. DeNofrio, and K.L. Brayman Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients Clin Biochem 34 2001 17 22 (Pubitemid 32178501)
29. J.F. Gummert, M.J. Barten, T. Van Gelder, M.E. Billingham, and R.E. Morris Pharmacodynamics of mycophenolic acid in heart allograft recipients: correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology Transplantation 70 2000 1038 1049
30. M.J. Barten, A. Tarnok, J. Garbade, H.B. Bittner, S. Dhein, and F.W. Mohr Pharmacodynamics of T-cell function for monitoring immunosuppression Cell Prolif 40 2007 50 63 (Pubitemid 46103690)